Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02962882 · ClinicalTrials.gov registry record · NA
Pressure Injury Prevention in the ICU With Multi-Layer Foam Dressings
A NA study of Pressure Incidence Prevention, sponsored by Molnlycke Health Care AB.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT02962882: Completed NA study of Pressure Incidence Prevention, sponsored by Molnlycke Health Care AB.
NCT02962882 is a NA study of Pressure Incidence Prevention that has completed, run by Molnlycke Health Care AB. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02962882, a NA study of Pressure Incidence Prevention, has completed, sponsored by Molnlycke Health Care AB.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
A Multi-Centre, Open, Non-controlled, Clinical Investigation to Evaluate the User Friendliness and Wear Time of Multi-layer Foam Dressings With Safetac® for Pressure Injury Prevention in the Intensive Care Unit
Primary Outcome
User friendliness judged by site staff, with the following variables; Ability to stay in place Facilitation of inspection Ease of reapplication Conformability to the body Overall impression of dressing \*NOTE: Since subjects typically left the ICU earlier than expected (the study protocol stipulated that the test dressing should be left in place for 3 days or longer, however typically the subjects left the ICU department after one day), not all subjects completed the full study period/all study
Conditions Studied
Interventions
- DEVICE Mepilex Border
Study Locations (2)
South Carolina
- Anmed Health - Anderson
- Roper Hospital - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-09-09 |
| Est. Completion | 2017-05-04 |
| Phase | NA |
What the finished NCT02962882 record still lists
NCT02962882 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Pressure Incidence Prevention appearing as the primary indexed condition, and to 1 intervention - of which Mepilex Border is the first listed.
NCT02962882 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT02962882 about?
NCT02962882 is a clinical study titled "Pressure Injury Prevention in the ICU With Multi-Layer Foam Dressings". A Multi-Centre, Open, Non-controlled, Clinical Investigation to Evaluate the User Friendliness and Wear Time of Multi-layer Foam Dressings With Safetac® for Pressure Injury Prevention in the Intensive Care Unit
What is the current status of trial NCT02962882?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-09-09. Estimated completion is 2017-05-04.
What conditions does trial NCT02962882 study?
This clinical trial studies the following conditions: Pressure Incidence Prevention.
What interventions are being tested in trial NCT02962882?
The interventions under investigation include: Mepilex Border (DEVICE).
Who is sponsoring clinical trial NCT02962882?
This trial is sponsored by Molnlycke Health Care AB, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02962882 being conducted?
This trial has 2 study locations across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02962882's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI